Voyager Therapeutics CFO Resigns; Internal Appointments Made Amidst Financial Restructuring

summarizeSummary

Voyager Therapeutics announced the resignation of its CFO, Nathan Jorgensen, effective May 8, 2026, and appointed Robin Swartz as Principal Financial Officer and Amy Quinlan as Principal Accounting Officer.

check_boxKey Events

• Chief Financial Officer Resigns

  Nathan Jorgensen, Ph.D., notified the company of his decision to resign from his position as Chief Financial Officer, effective May 8, 2026, to pursue a new opportunity. The company stated his resignation was not a result of any disagreement.

• New Principal Financial Officer Appointed

  Robin Swartz, age 55, currently the company's Chief Operating Officer and Chief Business Officer, was appointed to assume the roles of Principal Financial Officer and Treasurer, effective May 8, 2026. Ms. Swartz previously served as the company's Principal Financial Officer from April 2024 to July 2024.

• New Principal Accounting Officer Appointed

  Amy Quinlan, age 51, currently the company's Vice President of Finance, was appointed to assume the role of Principal Accounting Officer, effective May 8, 2026.

• Context of Financial Challenges

  This executive change follows the company's recent disclosure of a significant net loss of $119.7 million for 2025, a 41% workforce reduction, and a proposal to double its authorized common stock, indicating a period of financial restructuring and potential future dilution.

auto_awesomeAnalysis

The resignation of Chief Financial Officer Nathan Jorgensen comes at a critical juncture for Voyager Therapeutics, which recently reported significant net losses and a workforce reduction, and is seeking shareholder approval to double its authorized common stock. While the company states the resignation is not due to disagreement, a change in top financial leadership ahead of potential dilutive financing could raise investor questions about stability and future financial strategy. The appointments of Robin Swartz as Principal Financial Officer and Amy Quinlan as Principal Accounting Officer, both internal promotions with relevant experience, provide some continuity but do not fully offset the uncertainty created by the CFO's departure.